IVF Treatment

Ahead of its IPO, Gaudium IVF raised 49.5 crore by allocating 6.26 million shares to four anchor investors on February 19

The unlisted shares of Gaudium IVF were trading at ₹91 in the grey market, commanding a premium of ₹12 or 15 per cent from the upper end price of ₹79

Gaudium IVF IPO comprises a fresh issue of 11.3 million equity shares worth up to ₹90 crore and an OFS of up to 9.49 million equity shares worth up to ₹75 crore

Employee attrition, according to the RHP, stood at 31 per cent for the period ended September 30, 2025, following elevated levels of 63 per cent in FY25 and 51 per cent each in FY24 and FY23

Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF clinics, targeting an all-India rollout by Q1FY26.

Pavel Durov so far has six children from three partners and has more than 100 other children in 12 countries through sperm donation

From age-related decline to pollution, stress and medical treatments, experts explain why sperm freezing is becoming an increasingly sensible choice for modern men

Is infertility only a woman’s issue? Do stress, supplements, or sex positions improve fertility? In this episode of our fact-check series, we debunk the most common myths about infertility, IVF

From sperm count and irregular periods to IVF and birth control pills, fertility doctors explain the misconceptions that add stigma, delay treatment, and fuel anxiety for couples trying to conceive

The company raised the funds at a valuation of Rs 1,000 crore, which will help it expand its network of fertility specialists, invest in technology, and deepen clinical capabilities

Indian IVF providers are deploying AI for embryo and sperm selection to improve precision, reduce costs, and widen fertility access amid growing demand for reproductive care

As more couples turn to IVF for parenthood, understanding the step-by-step process, costs and success rates is key to navigating this complex journey

Rising infertility, delayed motherhood and increased awareness are driving demand for egg freezing across India, with clinics reporting a surge in inquiries from urban women

As infertility rates climb and fertility rates fall, IVF and embryologists continue to offer millions the promise of parenthood

The breakthrough could prevent inherited diseases, but raises ethical concerns around access and genetic enhancement

Fertility services provider Indira IVF Hospital Ltd has confidentially filed draft papers with markets regulator Sebi to raise funds through an initial public offering (IPO), according to a public announcement on Wednesday. The development comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favourable demographics. In a public announcement, Indira IVF stated that it has submitted "the pre-filed draft red herring prospectus with Sebi and the stock exchanges... in relation to the proposed initial public offering of its equity shares on the main board of the stock exchanges." The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). Meanwhile, market sources said Gaudium IVF and Women Healt

With India's fertility rate below replacement level, major IVF providers are moving into Tier 2 and 3 cities to meet rising demand and boost access to fertility services

Fact-check Friday: Delaying motherhood? Experts bust common myths about IVF success after 40 and explain what really affects your chances of pregnancy

Can IVF help you get pregnant at 40 or beyond? Is it really a shortcut to motherhood?

Fertility clinic chain Indira IVF Hospital has withdrawn its draft IPO papers, which were filed through the confidential route, an update with markets regulator Sebi showed on Tuesday. The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). The preliminary IPO papers were received by the Securities and Exchange Board of India (Sebi) on February 13, however, "draft offer document (was) withdrawn on March 19, 2025" by the company without disclosing any reasons. Last week, PhysicsWallah joined the league of a handful of companies that took confidential filing routes for its IPO. In 2024, food delivery giant Swiggy and supermart major Vishal Mega Mart successfully floated their respective initial share sales after making confidential filings. Before this, online hotel aggregator OYO took the .